Publication Month: Oct 2022 | Report Code: TIPRE00029768 | No. of Pages: 267 | Category: Medical Device | Status: Published
The growth of the market is attributed to the technological advancements in mass spectrometry and growing applications of lipidomics in biomedical sciences. However, premium product pricing limits the lipidomics equipment market growth. Lipidomics, an emerging discipline of biomedical sciences, involves the characterization of complex lipidomes. The lipidome characterization is based on a system-level quantitation and the detection of several networks & pathways of cellular lipids, along with their interaction with other moieties and proteins. The need for accurate disease diagnosis, growth in demand for personalized medicines, technological advancements in lipidomics, and huge investments from the public and private sectors in R&D activities would further continue to fuel the market growth during the forecast period.
Asia Pacific has registered as the fastest-growing region in the global lipidomics equipment market. China, Japan, and India are among the key contributors to the market in this region. Investments from international players in China and India, growing government support in countries, flourishing collaborations among research organizations, rising number of lipidomics equipment research institutes, and advancements in healthcare infrastructure are among the key factors fueling the lipidomics equipment market in Asia Pacific.
Get more information on this report :
Market InsightsMass spectrometers are commonly used for the identification and quantification of lipids. The high-energy collisional-activated dissociation (CAD) technique of mass spectrometry results in charge remote fragmentation (CRF) reactions, which help detect the location of small structural bond details. Several advanced mass spectrometers, including sector mass spectrometry, matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF), liquid chromatography-mass spectrometry (LC-MS), and tandem mass spectrometer have been made available for researchers and technicians. Further, these instruments are being integrated with automation, miniaturization, artificial intelligence (AI), and smart technologies to enhance their efficiencies and accuracies.
In 2018, Thermo Scientific launched Genesys 50 UV/vis spectrometer that has a single cell configuration, which is suitable for low sample throughput needs, with a removable, washable sampling compartment for easy clean-up. In the same year, Shimadzu, in collaboration with PREMIER Biosoft, launched Shimadzu's LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry (MS) system for lipidomics and glycomics data analysis; the product features informatics support powered by software solutions of PREMIER Biosoft. In 2019, TTP Venus Ltd introduced a range of new micropumps with enhanced performance, higher flow rates, high pressures, and longer life. The introduction of such new enhanced mass spectrometers and micropumps is boosting the growth of the lipidomics equipment market.
Based on type, the lipidomics equipment market is segmented into targeted and untargeted. The targeted segment held a larger share of the market in 2021, and it is anticipated to register a higher CAGR during 2021–2028. Targeted lipidomics equipment are mainly used for analyzing signal processing pathways. Rapid advancements in techniques and their applications are capable of making a timely review of these aspects essential.
Get more information on this report :
Offering-Based InsightsBased on offering, the lipidomics equipment market is segmented into MS-based lipidomics techniques, assays for lipid metabolism, lipid flux using isotope-labeled precursors, software & services, and others. The MS-based lipidomics techniques segment accounted for the largest market share in 2021, and it is expected to register the highest CAGR in the market during the forecast period.
Based on service, the lipidomics equipment market is segmented into biomarker identification, bioinformatic analysis & data interpretation, molecular analysis of a broad spectrum of phospholipids (lipid fingerprinting), analysis & identification of unusual lipids, semiquantitative & quantitative analysis, lipid flux studies, and others. The biomarker identification segment held the largest share of the market in 2021, and it is estimated to register the highest CAGR during the forecast period. Biomarker identification is the most widely used method for the diagnoses of chronic diseases, such as cancer and kidney disorders.
Based on end user, the lipidomics equipment market is segmented into molecular research, cellular research, clinical research, tissue & organ research, data research, organism research, technical services & prototyping, production, and others. The molecular research segment accounted for the largest market share in 2021, and it is estimated to register the highest CAGR during the forecast period.
Companies operating in the lipidomics equipment market are adopting the product innovations strategy to meet the evolving customer demands across the world, which further permits them to maintain their brand name in the global market.
The lipidomics equipment market includes Thermofisher Scientific; Creative Proteomics; IonBench; Shimadzu Europe GMbH; Bruker; Agilent Technologies Inc; PerkinElmer, Inc.; Sciex; Metabolon, Inc.; and Cayman Chemical. These players focus on expanding, diversifying their market presence, and acquiring a novel customer base, thereby tapping prevailing business opportunities.
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.